Evidence map›Paper›PMID 37888076›Full record

ArticleJournal of personalized medicine2023

Narrating the Genetic Landscape of Human Class I Occlusion: A Perspective-Infused Review.

Iqbal M Lone, Osayd Zohud, Kareem Midlej, Obaida Awadi, Samir Masarwa, Sebastian Krohn, Christian Kirschneck, Peter Proff, Nezar Watted, Fuad A Iraqi

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Iqbal M LoneDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.
Osayd ZohudDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0003-3530-1420
Kareem MidlejDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0003-0144-575X
Obaida AwadiCenter for Dentistry Research and Aesthetics, Jatt 45911, Israel.
Samir MasarwaCenter for Dentistry Research and Aesthetics, Jatt 45911, Israel.
Sebastian KrohnDepartment of Orthodontics, University Hospital of Regensburg, University of Regensburg, 93053 Regensburg, Germany.
Christian KirschneckDepartment of Orthodontics, University Hospital of Regensburg, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-9473-8724
Peter ProffDepartment of Orthodontics, University Hospital of Regensburg, University of Regensburg, 93053 Regensburg, Germany.
Nezar WattedCenter for Dentistry Research and Aesthetics, Jatt 45911, Israel.
Fuad A IraqiDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0001-5525-206X
Tel Aviv University · ILUniversity of Regensburg · DEArab American University · PS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review examines a prevalent condition with multifaceted etiology encompassing genetic, environmental, and oral behavioral factors. It stands as a significant ailment impacting oral functionality, aesthetics, and quality of life. Longitudinal studies indicate that malocclusion in primary dentition may progress to permanent malocclusion. Recognizing and managing malocclusion in primary dentition is gaining prominence. The World Health Organization ranks malocclusions as the third most widespread oral health issue globally. Angle's classification system is widely used to categorize malocclusions, with Class I occlusion considered the norm. However, its prevalence varies across populations due to genetic and examination disparities. Genetic factors, including variants in genes like MSX1, PAX9, and AXIN2, have been associated with an increased risk of Class I occlusion. This review aims to provide a comprehensive overview of clinical strategies for managing Class I occlusion and consolidate genetic insights from both human and murine populations. Additionally, genomic relationships among craniofacial genes will be assessed in individuals with Class I occlusion, along with a murine model, shedding light on phenotype-genotype associations of clinical relevance. The prevalence of Class I occlusion, its impact, and treatment approaches will be discussed, emphasizing the importance of early intervention. Additionally, the role of RNA alterations in skeletal Class I occlusion will be explored, focusing on variations in expression or structure that influence craniofacial development. Mouse models will be highlighted as crucial tools for investigating mandible size and prognathism and conducting QTL analysis to gain deeper genetic insights. This review amalgamates cellular, molecular, and clinical trait data to unravel correlations between malocclusion and Class I phenotypes.

Indexed as

Class I occlusion (CIO)epigenetics-wide association study (EWAS)genome-wide association study (GWAS)micro and small RNA analysisprevalencequantitative trait loci (QTL) mapping

Identifiers

PMID37888076
PMCPMC10608728
OpenAlexW4387408269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.